Evaluation of the impact of a PsychoEducational intervention on knowledge levels and Psychological outcomes for schizophrenic patients and their carers in Jordan

Evaluation of the impact of a PsychoEducational intervention on knowledge levels and Psychological outcomes for people diagnosed with schizophrenia and their carers in Jordan: A randomized controlled trial and process evaluation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN78084871

Enrollment

144

Registered

2013-12-16

Start date

2012-09-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia Mental and Behavioural Disorders Schizophrenia, unspecified

Interventions

Intervention: treatment as usual + psychoeducational intervention Based on Atkinson and Coia model. It consists of six booklets each fortnight covering essential topics to patients and carers: 1. Ge

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients: 1. Diagnosed with schizophrenia or schizoaffective disorder based on the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) 2. Able to read Arabic or English language 3. Written consent 5. Aged 18 or over, either sex Caregivers: 1. Primary caregivers - caregivers who mostly involved in patients' care 2. Able to read Arabic or English language 3. Written consent 5. Aged 18 or over, either sex

Exclusion criteria

Exclusion criteria: Patients: 1. Any learning disability 2. Presence of known organic mental disorder 3. Had a history of substance abuse or current substance abuse 4. Living alone without caregivers or attended any psychosocial intervention previously Caregivers: Involved in caring for more than one patient with mental disorder

Design outcomes

Primary

Measure	Time frame
1. Patients' primary outcome is knowledge level about schizophrenia measured by knowledge about schizophrenia questionnaires (KASQ) 2. Carers' primary outcome is knowledge level about schizophrenia measured by knowledge about schizophrenia questionnaires (KASQ) All outcomes measured at baseline, end of treatment and three months follow up.	—

Secondary

Measure	Time frame
Patient: 1. Schizophrenia symptoms are measured by the positive and negative syndrome scale (PANSS) 2. Relapse with hospitalization is measured by the number of mental hospital re-admissions 3. Relapse with medication is calculated by the number of anti-psychotic drug dosage increases Caregivers: 1. Burden of care is measured by Family Burden Interview Schedule (FBIS) 2. Quality of life is measured by Schizophrenia-Caregiver Quality of Life (S-CQoL) All outcomes measured at baseline, end of treatment and three months follow up.	—

Measure

Time frame

Patient: 1. Schizophrenia symptoms are measured by the positive and negative syndrome scale (PANSS) 2. Relapse with hospitalization is measured by the number of mental hospital re-admissions 3. Relapse with medication is calculated by the number of anti-psychotic drug dosage increases Caregivers: 1. Burden of care is measured by Family Burden Interview Schedule (FBIS) 2. Quality of life is measured by Schizophrenia-Caregiver Quality of Life (S-CQoL) All outcomes measured at baseline, end of treatment and three months follow up.

—

Countries

Jordan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 21, 2026